Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized withdrawal study of lurasidone for maintenance treatment of schizophrenia
2011-001711-31Phase 3Completed
- Sponsor
- Sunovion
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Lurasidone arm with Placebo arm (2 arms). Started Mar 2012; status: completed.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2011-001711-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001711-31.